Meadow Creek Investment Management’s Emergent Biosolutions EBS Stock Holding History

Meadow Creek Investment Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$296K	Buy	5,654 +440	+8%	+$20.5K	0.01%	897
2019 Q2	$252K	Buy	5,214 +66	+1%	+$3.16K	0.01%	959
2019 Q1	$260K	Hold	5,148	–	–	0.01%	927
2018 Q4	$305K	Buy	5,148 +22	+0.4%	+$1.42K	0.01%	810
2018 Q3	$337K	Buy	5,126 +22	+0.4%	+$1.28K	0.01%	878
2018 Q2	$258K	Hold	5,104	–	–	0.01%	902
2018 Q1	$269K	Buy	5,104 +638	+14%	+$31.8K	0.01%	887
2017 Q4	$208K	Buy	4,466 +770	+21%	+$32.4K	﹤0.01%	979
2017 Q3	$150K	Buy	3,696 +1,034	+39%	+$37.4K	﹤0.01%	1022
2017 Q2	$90K	Buy	2,662 +1,342	+102%	+$41.4K	﹤0.01%	1135
2017 Q1	$38K	Sell	1,320 -1,276	-49%	-$38.8K	﹤0.01%	1209
2016 Q4	$85K	Buy	+2,596	New	+$77.8K	﹤0.01%	978

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Meadow Creek Investment Management's EBS Position: Q3 2019 in Review

Meadow Creek Investment Management increased its Emergent Biosolutions (EBS) stake by 8.4% in Q3 2019, buying an estimated $20.5K and bringing the position to 5,654 shares worth $296K. The position accounts for 0.01% of the portfolio, ranked #897.

Meadow Creek Investment Management first reported a position in EBS in Q4 2016 and has held it in 12 quarters since. The position peaked at $337K in Q3 2018. 244 funds tracked by Wall St. Rank hold EBS as of Q3 2019.

Meadow Creek Investment Management held 5,654 shares of Emergent Biosolutions worth $296K as of Q3 2019.
Meadow Creek Investment Management bought 440 Emergent Biosolutions shares in Q3 2019, an estimated $20.5K.
Emergent Biosolutions made up 0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #897 holding.
Meadow Creek Investment Management first reported a position in Emergent Biosolutions in Q4 2016 and has held it in 12 quarters since.
Meadow Creek Investment Management's Emergent Biosolutions position peaked at $337K in Q3 2018.
244 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.